Hansa will apply to the EMA to convert Idefrix’s conditional approval into full marketing authorisation.

Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial One hundred ...

The number of unrelated cord blood (U-CB) transplantations performed has rapidly increased during the past decade. However, few studies have compared the incidences and risk factors of chronic GVHD ...

Jak1/2 inhibitor ruxolitinib is a promising agent for treating steroid-refractory GvHD after allogeneic hematopoietic stem cell transplantation (SCT) to produce quick and durable responses. However, ...

Graft-versus-host disease (GVHD) is a life-threatening condition that can occur after an allogeneic stem cell transplant, which is a procedure that some blood cancer patients choose as it may offer ...

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

What is Graft versus Host Disease? This condition typically occurs during a stem cell or bone marrow transplant from another individual. GvHD occurs when lymphocytes (immune cells) in the donor tissue ...

(BPT) - For many people with cancer and other life-threatening diseases, stem cell transplants provide hope and can impact the course of the disease, but they also come with risks. One of those risks ...

While hematopoietic stem cell transplantation (HSCT) may offer a cure for patients with blood cancers, the chances of that are dashed if the patient develops graft-vs-host disease (GvHD). This happens ...

Global Graft Versus Host Disease (GvHD) Treatment Market · GlobeNewswire Inc. Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment Market Report 2024" report has ...

Hutchinson Center researchers have developed a new drug therapy that significantly reduces death from gastrointestinal graft-vs.-host disease in allogeneic stem-cell transplant patients. By adding a ...